Label: LORATADINE tablet
- NDC Code(s): 68210-4110-1
- Packager: Spirit Pharmaceuticals LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated December 13, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient
- Purpose
- Uses
- Warnings
- Ask a doctor before use if
- When usung this product
- Stop use and ask a doctor if
- If pregnant or breast-feeding,
- Keep out of reach of children
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
-
PRINCIPAL DISPLAY PANEL
Compare to the active ingredient in Claritin®†
NON-DROWSY*
Original Prescription Strength
Loratadine Tablets, 10 mg / Antihistamine
Indoor & Outdoor Allergies
24 Hour Relief of: • Sneezing • Runny Nose • Itchy, Watery Eyes • Itchy Throat or Nose
365 Tablets
*When taken as directed
See Drug Facts Panel†This product is not manufactured or distributed by Bayer Healthcare, LLC, owner of the registered trademark Claritin®.
-
INGREDIENTS AND APPEARANCE
LORATADINE
loratadine tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68210-4110 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE 10 mg Inactive Ingredients Ingredient Name Strength LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) STARCH, CORN (UNII: O8232NY3SJ) MAGNESIUM STEARATE (UNII: 70097M6I30) SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) Product Characteristics Color white (White to off white) Score no score Shape ROUND Size 6mm Flavor Imprint Code G;10 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68210-4110-1 365 in 1 BOTTLE; Type 0: Not a Combination Product 09/11/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA210722 09/11/2020 Labeler - Spirit Pharmaceuticals LLC (179621011)